---
input_text: 'White matter disease: Targeted aspartoacylase gene therapy reverts Canavan
  disease. '
raw_completion_output: |-
  primary_disease: Canavan disease
  medical_actions: Targeted aspartoacylase gene therapy
  symptoms: 
  chemicals: 
  action_annotation_relationships: Targeted aspartoacylase gene therapy TREATS Canavan disease
prompt: |+
  Split the following piece of text into fields in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Targeted aspartoacylase gene therapy TREATS Canavan disease

  ===

extracted_object:
  primary_disease: MONDO:0010079
  medical_actions:
    - Targeted aspartoacylase gene therapy
  action_annotation_relationships:
    - subject: Targeted gene therapy
      predicate: TREATS
      object: Canavan disease
      qualifier: MONDO:0010079
      subject_extension: aspartoacylase gene
named_entities:
  - id: MONDO:0008090
    label: Central Nervous System (CNS) disorders
  - id: MAXO:0001001
    label: gene therapy
  - id: HP:0002011
    label: CNS disorders
  - id: MONDO:0019046
    label: Leukodystrophies
  - id: HP:0002415
    label: Leukodystrophies
  - id: MONDO:0010079
    label: Canavan disease
  - id: MONDO:0005071
    label: neurologic disease
  - id: CHEBI:21547
    label: N-acetyl-aspartate (NAA)
  - id: CHEBI:17053
    label: l-aspartic acid
  - id: CHEBI:30089
    label: acetate
  - id: CHEBI:9661
    label: Glyceryl triacetate
  - id: MAXO:0001394
    label: Oral administration
  - id: HP:0001355
    label: Megalencephaly
  - id: MAXO:0000016
    label: Cell therapy
  - id: MONDO:0005066
    label: Metabolic Disorders
  - id: HP:0040289
    label: diseases of the central nervous system (CNS)
  - id: CHEBI:15765
    label: L-dopa
  - id: CHEBI:18243
    label: dopamine
  - id: CHEBI:16865
    label: GABA
  - id: MONDO:0005180
    label: Parkinson's disease
  - id: MAXO:0000504
    label: Tracheostomy
  - id: MAXO:0000527
    label: Physical examination
  - id: MAXO:0001189
    label: Laryngoscopy
  - id: HP:0000158
    label: Macroglossia
  - id: HP:0002870
    label: Obstructive sleep apnea
